Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc. (COCP) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
cocp · stock forecast · 1 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 1 Wall Street analysts in the past 3 months
Buy
1 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $1.01
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $0.96 | ↓ 5.00% |
1-day model range: $0.94–$0.98. Peak: $0.98 (-5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · COCP · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-06-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-04-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-03-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-01-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-12-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-10-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-08-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-08-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Cocrystal Pharma, Inc. (COCP) stock. Of the recent 15 rating actions, 0 were upgrades and 0 were downgrades. 1 analysts currently cover COCP.
Analyst Recommendation Trends
COCP analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$3M
Revenue Next Year
$2M
↓ 20.0% YoY
EPS This Year
$-1.93
EPS Next Year
$-0.80
↓ 58.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast COCP EPS of $-1.93 for the current fiscal year, based on estimates from 3 analysts. The COCP revenue forecast is $3M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The COCP stock forecast is supported by two independent data sources: analyst consensus ratings from 1 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus COCP price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The COCP short-term stock prediction for tomorrow is $0.96 (-5.00%).
Cocrystal Pharma, Inc. trades on NASDAQ under the ticker COCP. The COCP stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
COCP forecast · 8 questionsAccording to 1 Wall Street analysts, the average 12-month COCP price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $1.01.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.